The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate ...

What Happened? Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.2% in the afternoon session ...

This proprietary system employs specialized algorithms to identify early signs of litigation trends in federal litigation filings. Click here to learn more about Law.com Radar's new suit alerting and ...

Asian equities were mixed, as Japan and South Korea outperformed, while Mainland China and Hong Kong underperformed.

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Eli Lilly remains a top GARP opportunity, with Q3 results reinforcing its robust business growth and dominance in incretin ...

South Korean government, major companies to acquire Nvidia's GPUs to build AI infrastructure, ecosystem to 'fuel Korea innovation, industries and jobs' - Anadolu Ajansı ...

Q3 2025 Earnings Call Transcript October 29, 2025 NiSource Inc. misses on earnings expectations. Reported EPS is $0.19 EPS, ...

In addition to purchase of Nvidia's chips, Samsung to also make use of chip giant's Omniverse platform to scale ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Eli Lilly hiked its outlook as sales soared for its popular weight-loss drugs Zepbound and Mounjaro.  The company also ...

A new drug-sales king has been crowned. Eli Lilly’s diabetes and weight-loss drug tirzepatide, marketed under the Mounjaro ...